Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(3,4-dihydroxyphenyl)ethanol
2. 3,4-dihydroxyphenylethanol
3. Beta-3,4-dihydroxyphenylethyl Alcohol
4. Dopet
1. 10597-60-1
2. 3,4-dihydroxyphenylethanol
3. 2-(3,4-dihydroxyphenyl)ethanol
4. 4-(2-hydroxyethyl)benzene-1,2-diol
5. Dopet
6. 3,4-dihydroxyphenethyl Alcohol
7. 3-hydroxytyrosol
8. 1,2-benzenediol, 4-(2-hydroxyethyl)-
9. 2-(3,4-dihydroxyphenyl)ethyl Alcohol
10. 3,4-dihydroxyphenethylalcohol
11. 4-(2-hydroxyethyl)-1,2-benzenediol
12. Beta-3,4-dihydroxyphenylethyl Alcohol
13. Dihydroxyphenylethanol
14. Mfcd01320529
15. Qeu0ne4o90
16. Chebi:68889
17. Unii-qeu0ne4o90
18. Dopaol
19. 3,4-dihydroxy-1-benzeneethanol
20. 4-(2-hydroxy-ethyl)-benzene-1,2-diol
21. Hydroxytyrosol [mi]
22. Schembl44363
23. Hydroxytyrosol [inci]
24. 3,4-dhpea
25. Hydroxytyrosol [who-dd]
26. Chembl1950045
27. Ba2774
28. Juubchwrxwpffh-uhfffaoysa-
29. Dtxsid70147451
30. Ba 2774
31. Bcp31094
32. Hy-n0570
33. Zinc2379217
34. 2-(3,4-di-hydroxyphenyl)-ethanol
35. S3826
36. 3-hydroxytyrosol, >=98% (hplc)
37. 3-hydroxytyrosol, Analytical Standard
38. Akos003368868
39. Ac-5308
40. Ccg-266246
41. Db12771
42. As-10017
43. Sy017402
44. Db-008830
45. Am20020163
46. Cs-0009107
47. D2756
48. Ft-0600597
49. Ft-0670206
50. N2302
51. 597d601
52. A801346
53. Q744577
54. Q-100040
55. Brd-k04809113-001-01-7
56. 3,4-dihydroxyphenethyl Alcohol;3,4-dihydroxyphenyl Ethanol
| Molecular Weight | 154.16 g/mol |
|---|---|
| Molecular Formula | C8H10O3 |
| XLogP3 | -0.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 154.062994177 g/mol |
| Monoisotopic Mass | 154.062994177 g/mol |
| Topological Polar Surface Area | 60.7 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 116 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Hydroxytyrosol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxytyrosol, including repackagers and relabelers. The FDA regulates Hydroxytyrosol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxytyrosol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxytyrosol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxytyrosol supplier is an individual or a company that provides Hydroxytyrosol active pharmaceutical ingredient (API) or Hydroxytyrosol finished formulations upon request. The Hydroxytyrosol suppliers may include Hydroxytyrosol API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxytyrosol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Hydroxytyrosol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxytyrosol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxytyrosol GMP manufacturer or Hydroxytyrosol GMP API supplier for your needs.
A Hydroxytyrosol CoA (Certificate of Analysis) is a formal document that attests to Hydroxytyrosol's compliance with Hydroxytyrosol specifications and serves as a tool for batch-level quality control.
Hydroxytyrosol CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxytyrosol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxytyrosol may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxytyrosol EP), Hydroxytyrosol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxytyrosol USP).
LOOKING FOR A SUPPLIER?
